5th Annual STING & TLR-Targeted Therapies Summit, San Diego, CA, June 19-20, 2024

Conference

genOway presentation

Event
-
June 19, 2024

June 19-20, 2024

Advancing the Next Wave of Immunotherapeutics: STING, TLR & Beyond

‍

‍

genOway's presentation on June 19, 2024 | 1 p.m. PDT:

Profiling STING and TLR-Targeted Therapies in Preclinical Models

  • Focus on STING humanized mouse models and BRGSF-HIS, hCD34+ reconstituted mice featuring human lymphoid and myeloid compartments
  • Characterization of the immune responses
  • Showcase of assessment of STING and TLR-targeting agents in these models

‍

▶ Get more information on the STING & TLR-Targeted Therapies Summit 2024 here

5th Annual STING & TLR-Targeted Therapies Summit, San Diego, CA, June 19-20, 2024

Get in touch

Let us know how we can help

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
Festival of Biologics, Basel Switzerland, October 13-15, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Lunch & Learn, October 7th, San Diego Biomedical Research Institute: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Oct 2026
Read on
BioJapan, Yokohama, October 7-9, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Lunch & Learn, October 6th, Salk Institute for Biological Studies: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe